Centrus Energy Corp. (LEU) Misses Q3 Earnings and Revenue Estimates
Centrus Energy Corp. (LEU) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.2 per share. This compares to a loss of $0.3 per share a year ago.
Should You Buy, Sell or Hold LEU Stock Before Q3 Earnings Release?
Centrus Energy gears up for Q3 results with revenues up 32% and a profit rebound expected, though an earnings beat remains unclear.
LEU vs. CCJ: Which Stock Has More Power for Growth Right Now?
As nuclear demand surges worldwide, Centrus Energy and Cameco stand out, but Centrus' HALEU edge makes it the brighter investment bet.
Centrus Energy's Revenues Slip 2% in 1H25: Recovery Ahead?
LEU's 1H25 revenues dip 2% as weak uranium sales offset solid gains in its Technical segment.
Centrus Energy: 5 Letters You Need To Know For The Next Decade - HALEU
Centrus Energy is the only U.S. company licensed to produce next-gen nuclear fuel (HALEU), positioning it for significant future growth. LEU's unique regulatory position and anticipated HALEU demand could drive dramatic revenue and profit expansion over the next decade. Despite strong long-term prospects, LEU trades at a steep valuation (80x earnings), with meaningful growth not expected until the 2030s.
Strength Seen in Centrus Energy (LEU): Can Its 12.1% Jump Turn into More Strength?
Centrus Energy (LEU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
LEU vs. UEC: Which Uranium Stock is the Smarter Bet Right Now?
Centrus Energy stands out with exclusive HALEU production rights, a strong backlog and better valuation compared with Uranium Energy.
LEU vs. UUUU: Which Uranium Stock is the Smarter Bet Right Now?
Centrus Energy and Energy Fuels face diverging growth paths as nuclear demand rises, with LEU gaining an edge on estimates and valuation.
Centrus Energy: Buying The Dip In A High-Yield, High-Risk Play
Centrus is the only listed U.S. supplier of enriched uranium, with a $3.6B backlog and $833M cash, giving visibility and financing flexibility. Revenue fell to $154.5M (down $34.5M YoY) due to lower SWU sales, but gross margin jumped to 35% and net income held steady at $28.9M. $60M investment in supply chain readiness, DOE contract extension for HALEU through 2026 (with option to 2034), and nearly one ton of HALEU already produced.
Centrus Energy Hit by Weak Uranium Sales: Recovery Ahead?
LEU's weak uranium sales drag Q2 results, but a $3.6B backlog underscores long-term strength despite near-term headwinds.
Should Investors Bet on Centrus Energy Stock Post Q2 Earnings Beat?
LEU surges 12% post-earnings as strong HALEU progress offsets concerns over year-over-year revenue and EPS declines.
Centrus Energy Corp. (LEU) Q2 2025 Earnings Call Transcript
Centrus Energy Corp. (NYSE:LEU ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants Amir V. Vexler - President, CEO & Director Kevin J.
